Research Topics
| A S KadishSummaryAffiliation: Albert Einstein College of Medicine Country: USA Publications
|
Detail Information
Publications
Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasiaA S Kadish
Department of Pathology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
J Natl Cancer Inst 89:1285-93. 1997..g., lymphocyte proliferation) against HPV in the natural history of HPV-associated neoplasia and to identify antigenic sequences of the HPV16 proteins E6 and E7 against which an immune response may confer protection...- Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptideAnna S Kadish
Department of Pathology, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York 10461, USA
Cancer Epidemiol Biomarkers Prev 11:483-8. 2002.... - Vaccine strategies for human papillomavirus-associated cancersAnna S Kadish
Departments of Pathology, Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine, 1695 Eastchester Road, Suite 601, Bronx, NY 10461, USA
Curr Opin Oncol 17:456-61. 2005..To review novel immunologic strategies for the prevention and treatment of human papillomavirus infection and associated diseases. Both animal model systems and human protocols are discussed... - HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasiaG Y Ho
Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, NY, USA
Int J Cancer 78:281-5. 1998..Our results indicate that infection with HPV 16 is associated with high-grade lesions. Additional cofactors, such as cigarette smoking, may be required as a carcinogen to advance HPV-infected cells toward neoplastic progression... - Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasiaG Y Ho
Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA
Int J Cancer 78:594-9. 1998..Vitamins C and E may play an independent protective role in development of CIN that needs to be confirmed in prospective studies... - Combined human papillomavirus DNA and human papillomavirus-like particle serologic assay to identify women at risk for high-grade cervical intraepithelial neoplasiaMark H Einstein
Albert Einstein College of Medicine, Bronx, NY 10461, USA
Int J Cancer 120:55-9. 2007..HPV VLP assays may be useful as an adjunct to HPV DNA testing in a subset of patients that needs to be defined by further studies... 
Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia IIIMark H Einstein
Albert Einstein College of Medicine, and Albert Einstein Cancer Center, Bronx, NY 10461, USA
Gynecol Oncol 106:453-60. 2007..bovis BCG heat shock protein (Hsp65) covalently linked to the entire sequence of HPV 16 E7. This trial was designed to evaluate the efficacy and toxicities of HspE7 in women with CIN III...- Anogenital neoplasia in AIDSMark H Einstein
Albert Einstein College of Medicine, Bronx, New York 10461, USA
Curr Opin Oncol 16:455-62. 2004..Current treatment strategies are not effective in clearing anogenital HPV infection and need improvement. Immunotherapy with novel vaccines will provide both prevention and therapy for these common malignancies... - Utilization of the human genome sequence localizes human papillomavirus type 16 DNA integrated into the TNFAIP2 gene in a fatal cervical cancer from a 39-year-old womanMark H Einstein
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women's Health, Albert Einstein College of Medicine/Montefiore Medical Center, 1300 Morris Park Avenue, Bronx, NY 10461, USA
Clin Cancer Res 8:549-54. 2002..Availability of the human genome sequence will facilitate identification of cellular genes involved in cervical cancer by high-throughput analysis of viral integration sites... - A phase II trial of interleukin-12 in patients with advanced cervical cancer: clinical and immunologic correlates. Eastern Cooperative Oncology Group study E1E96Scott Wadler
Weill Medical College of Cornell University, New York, NY, USA
Gynecol Oncol 92:957-64. 2004..Interleukin-12 (IL-12) is a potent immunopotentiator of T-cell function, and has been shown in phase I clinical trials to be tolerable...